14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication

• Váldodahkkit: Mercedes Bermejo (Dahkki), Juan Ambrosioni (Dahkki), Guiomar Bautista (Dahkki), Núria Climent (Dahkki), Elena Mateos (Dahkki), Cristina Rovira (Dahkki), Rafael Duarte (Dahkki), Francisco Cervantes (Dahkki), Montserrat Plana (Dahkki), José M. Miró (Dahkki), José Alcamí (Dahkki), Mayte Coiras (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2017-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.